医药前沿
醫藥前沿
의약전연
Yiayao Qianyan
2015年
30期
14-15
,共2页
原发性甲状腺功能亢进症%甲状腺全切术%甲状腺次全切术%心功能%肝功能
原髮性甲狀腺功能亢進癥%甲狀腺全切術%甲狀腺次全切術%心功能%肝功能
원발성갑상선공능항진증%갑상선전절술%갑상선차전절술%심공능%간공능
Primary hyperthyroidism%All cut method of the thyroid gland%All thyroid times cut method%Cardiac function%Liver function
目的：探讨甲状腺全切术治疗原发性甲亢的疗效及对心功能和肝功能的影响；方法将100例原发性甲亢患者随机分为研究组、对照组各50例，分别行甲状腺全切术和甲状腺次全切术，评价两组手术疗效和心、肝功能指标变化，随访1年，比较复发率；结果：对照组中发生短暂性甲状腺功能减退21例，优于研究组（P＜0.05），但研究组未出现复发患者，明显优于对照组（P＜0.05）。研究组术中出血量和手术时间均明显少于对照组（P＜0.05）。术后，两组心功能组间比较，研究组改善程度均明显优于对照组（P＜0.05）；两组患者术后肝功能各项指标组间比较，研究组改善程度均明显优于对照组（P＜0.05）。随访1年，研究组患者无甲亢复发病例；结论：综上所述，甲状腺全切术治疗原发性甲亢疗效确切，甲亢复发率低，并可以显著改善心脏功能和肝功能，安全有效，优于甲状腺次全切术。
目的：探討甲狀腺全切術治療原髮性甲亢的療效及對心功能和肝功能的影響；方法將100例原髮性甲亢患者隨機分為研究組、對照組各50例，分彆行甲狀腺全切術和甲狀腺次全切術，評價兩組手術療效和心、肝功能指標變化，隨訪1年，比較複髮率；結果：對照組中髮生短暫性甲狀腺功能減退21例，優于研究組（P＜0.05），但研究組未齣現複髮患者，明顯優于對照組（P＜0.05）。研究組術中齣血量和手術時間均明顯少于對照組（P＜0.05）。術後，兩組心功能組間比較，研究組改善程度均明顯優于對照組（P＜0.05）；兩組患者術後肝功能各項指標組間比較，研究組改善程度均明顯優于對照組（P＜0.05）。隨訪1年，研究組患者無甲亢複髮病例；結論：綜上所述，甲狀腺全切術治療原髮性甲亢療效確切，甲亢複髮率低，併可以顯著改善心髒功能和肝功能，安全有效，優于甲狀腺次全切術。
목적：탐토갑상선전절술치료원발성갑항적료효급대심공능화간공능적영향；방법장100례원발성갑항환자수궤분위연구조、대조조각50례，분별행갑상선전절술화갑상선차전절술，평개량조수술료효화심、간공능지표변화，수방1년，비교복발솔；결과：대조조중발생단잠성갑상선공능감퇴21례，우우연구조（P＜0.05），단연구조미출현복발환자，명현우우대조조（P＜0.05）。연구조술중출혈량화수술시간균명현소우대조조（P＜0.05）。술후，량조심공능조간비교，연구조개선정도균명현우우대조조（P＜0.05）；량조환자술후간공능각항지표조간비교，연구조개선정도균명현우우대조조（P＜0.05）。수방1년，연구조환자무갑항복발병례；결론：종상소술，갑상선전절술치료원발성갑항료효학절，갑항복발솔저，병가이현저개선심장공능화간공능，안전유효，우우갑상선차전절술。
ObjectiveTo explore the full cut method curative effect of treatment for primary hyperthyroidism thyroid, and effects on cardiac function and liver function.Methods100 cases of primary hyperthyroidism patients were randomly divided into research group and the control group, 50 cases of thyroid full cut method respectively and thyroid full cut method, evaluating the effect of two groups of surgery and heart, liver function index changes, followed up for 1 year, compare the recurrence rate.ResultsIn transient hypothyroidism 21 cases in the control group, is better than that of group (P < 0.05), but the team did not appear a relapse patients, significantly better than the control group (P < 0.05). Team intraoperative blood loss and operation time were significantly less than the control group (P < 0.05). Postoperatively, the comparison between the two groups of cardiac function groups, improved group were significantly better than that of control group (P < 0.05); Comparison between the two group patients postoperative liver function indicators, improved group were significantly better than that of control group (P < 0.05). No recurrence of hyperthyroidism cases were followed up for 1 year, the team.ConclusionTo sum up, for the treatment of thyroid cutting all primary hyperthyroidism curative effect, hyperthyroidism recurrence rate is low, and can significantly improve cardiac function and liver function, safe and effective, all cut method is better than that of thyroid times.
